Nucleic Acids Research, 2001, Vol. 29, No. 14 2905-2919
© 2001 Oxford University Press
Estrogen receptor interaction with estrogen response elements
Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY 40292, USA
Received April 11, 2001; Revised and Accepted June 1, 2001.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
The estrogen receptor (ER) is a ligand-activated enhancer protein that is a member of the steroid/nuclear receptor superfamily. Two genes encode mammalian ER: ER
and ERß. ER binds to specific DNA sequences called estrogen response elements (EREs) with high affinity and transactivates gene expression in response to estradiol (E2). The purpose of this review is to summarize how natural and synthetic variations in the ERE sequence impact the affinity of ER–ERE binding and E2-induced transcriptional activity. Surprisingly, although the consensus ERE sequence was delineated in 1989, there are only seven natural EREs for which both ER binding affinity and transcriptional activation have been examined. Even less information is available regarding how variations in ERE sequence impact ERß binding and transcriptional activity. Review of data from our own laboratory and those in the literature indicate that ER binding affinity does not relate linearly with E2-induced transcriptional activation. We suggest that the reasons for this discord include cellular amounts of coactivators and adaptor proteins that play roles both in ER binding and transcriptional activation; phosphorylation of ER and other proteins involved in transcriptional activation; and sequence-specific and protein-induced alterations in chromatin architecture. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
The estrogen receptor (ER) is a ligand-activated enhancer protein that is a member of the steroid/nuclear receptor superfamily that includes 60 different ‘classical’ members of the nuclear hormone receptor family; by comparison the fly proteome has 19 and the worm proteome has 220 (1). Nuclear receptors share a highly conserved structure and common mechanisms affecting gene transcription (2). Mammalian ER is encoded by two genes: alpha and beta (ER
and ERß) that function both as signal transducers and transcription factors to modulate expression of target genes (3). Here the term ER will refer to both ER and ERß whereas ER and ERß indicate that particular subtype. In response to ligand binding, ER undergoes conformational changes, termed ‘activation’, accompanied by dissociation of hsp90, hsp70 and other proteins (reviewed in 4), forming a ligand-occupied ER dimer (5).
Stimulation of target gene expression in response to 17ß-estradiol (E2), or other agonists, is thought to be mediated by two mechanisms: (i) ‘direct binding’ where E2-liganded ER (E2–ER) binds directly to a specific sequence called an estrogen response element (ERE) and interacts directly with coactivator proteins and components of the RNA polymerase II transcription initiation complex resulting in enhanced transcription (6); and (ii) ‘tethering’ where ER interacts with another DNA-bound transcription factor in a way that stabilizes the DNA binding of that transcription factor and/or recruits coactivators to the complex. In mechanism (ii) ER does not bind DNA. Examples of the tethering mechanism of ER transactivation include ER interaction with Sp1 in conferring estrogen responsiveness on uteroglobin (7), RAR (8), insulin-like growth factor-binding protein-4 (9), transforming growth factor (10), bcl-2 (11) and the LDL receptor (12) genes; ER interaction with USF-1 and USF-2 in the cathepsin D promoter (13); and ER and ERß interaction with AP-1 (14–16).
The focus of this review is how differences in ERE sequence impact ER binding affinity and transcriptional activation. While the effect of single nucleotide changes in each position of the glucocorticoid response element (GRE) on glucocorticoid receptor (GR) and progesterone receptor (PR) activity has been examined and reviewed (17–20), such detailed analysis is not complete for ER–ERE interaction (21) and there is limited information regarding the effect of ERE sequence on ERß activity (22–26).
ER and ERß are Class I nuclear receptors (NR) along with other the steroid receptors, e.g. glucocorticoid, mineralocorticoid, progesterone and androgen receptors (GR, MR, PR and AR, respectively) that bind to DNA as homodimers. ER differs from the other steroid receptors that bind to derivatives of a common response element [i.e. the consensus GRE: 5'-GGTACAnnnTGTTCT-3', where n is any nucleotide (20,27)] in that ER binds to the ERE: 5'-GGTCAnnnTGACC-3' (28). GR binds with highest affinity to 5'-GG T/G ACA G/T G G/A GGTACAnnnTGTTCT-3'; AR binds with highest affinity to 5'-GGTAC A/G CGGTGTTCT-5'; and PR binds 5'-G/A G G/T AC A/G TGGTGTTCT-3', where the slash indicates approximately equal preference for either nucleotide (20).
Class I NR differ from the class II NR [e.g. retinoic acid receptor (RAR), retinoid X receptor (RXR), vitamin D receptor (VDR), thyroid receptor (TR) and peroxisome proliferator activated receptor (PPAR)] that bind to their response elements, i.e. various spacings of 5'-AGGTCA-3', as heterodimers with RXR (29). Additionally, the NR superfamily includes ‘orphan receptors’, denoted as such because their endogenous ligands, if necessary, are either unknown, e.g. chicken ovalbumin upstream promoter transcription factor (COUP-TF), or have recently been identified, e.g. the pregnane X receptor/steroid X receptor (PXR/SXR) that binds steroids and xenobiotics (30). The evolutionary relationship among the steroid/nuclear receptors has been deduced by the high conservation in their DNA binding domains (DBDs) and in their less-conserved ligand binding domains (LBDs) and indicates that this large group of proteins arose from a common ancestral molecule (31). This common origin accounts for the similarities in mechanisms of DNA binding and transcriptional activation among NR superfamily members.
|
STRUCTURAL DOMAINS OF ER AND ERß
|
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
ER
and ERß have six domains named A–F from N- to C-terminus, encoded by 8–9 exons (32). The three major functional domains of the ER are: (i) an N-terminus (domains A and B) that modulates transcription in a gene- and cell-specific manner through Activation Function-1 (AF-1); (ii) a highly conserved central DBD, consisting of the C domain, comprised of two functionally distinct zinc fingers through which ER interacts directly with the DNA helix; and (iii) the LBD (domain E) that contains Activation Function-2 (AF-2). In ER, the F domain plays a role in distinguishing estrogen agonists versus antagonists, perhaps through interaction with cell-specific factors (33).
There is little conservation in amino acid sequence in the N-terminal regions of ER and ERß (34). Indeed, the activity of AF-1 in ERß is negligible compared with that of ER (26). The most conserved region between ER and ERß is the DBD featuring two cys–cys zinc fingers (CI and CII) with which the receptor interacts with the major groove and phosphate backbone of DNA, respectively (34). The specificity of the DBD in targeting ER for gene regulation was demonstrated by domain-swapping experiments in which the DBD of ER was switched with that of the GR. The chimeric receptor, containing AF-1 and AF-2 of ER and the DBD of GR, bound to GREs but up-regulated transcription in response to E2 (35), thus demonstrating the specificity of the DBD in target gene regulation.
|
ER INTERACTION WITH EREs |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
ER
and ERß bind with high affinity to EREs (Tables 1 and S1). The ERE was first identified by aligning sequences with shared homologies in the 5' flanking regions of the estrogen-regulated vitellogenin genes A1, A2, B1 and B2 from Xenopus laevis and chicken and the chicken apo-VLDLII gene (36). Four short blocks of sequence homology were identified at equivalent positions in the vitellogenin genes of both Xenopus and chicken. A short sequence with 2-fold rotational symmetry, i.e. the perfect palindrome: 5'-GGTCAnnnTGACC-3' (n, any nucleotide), located at similar positions upstream of the five vitellogenin genes was also present as two copies close to the 5' end of the chicken apo-VLDLII gene (36). The derived minimal consensus ERE sequence is a 13 bp palindromic inverted repeat (IR): 5'-GGTCAnnnTGACC-3' (37), and differs in only 2 bp in each half-site from the GRE (38). This ERE sequence was shown to act on a heterologous promoter in an orientation- and distance-independent manner, thus fitting the definition of an enhancer element, as understood at that time (37). Extension of the length of the ERE palindrome by an additional nucleotide in each arm of the IR, e.g. 5'-AGGTCAnnnTGACCT-3', forming a 15 bp palindromic IR, and the sequence of the nucleotides immediately flanking the ERE are important in determining the affinity with which ER binds the ERE (21,39–46).
|
Specific contacts between the ER dimer and the sugar–phosphate backbone of the ERE are important in sequence recognition and high affinity binding (47). Each ER monomer is bound to DNA in the major groove with the ER dimer located predominantly on one face of the DNA helix (47). Three specific amino acids within the ‘P box’ of zinc finger CI interact in the major groove in a sequence-specific manner (48). The fourth base pair of the ERE half site (AGGTCA) provides a positive contact for the P-box, whereas the third base pair (AGGTCA) provides binding energy (49–51). The CII zinc finger is involved in half-site-ERE spacing recognition and ER dimerization (52). Phosphate methylation interference assays showed that ER
forms the strongest interaction with the underlined nucleotides: 5'-GGTCAGCGTGACC-3' (47) whereas ethylation and thymine interference assays indicate ER contacts the underlined nucleotides in the chicken vitellogenin II ERE: 5'-CTGGTCACGCTGACCGG-3' (53). Thus, the technique used to analyze ER–DNA contact gives differences in nucleotide recognition by ER.
There has been controversy over whether ER can bind to an ERE half-site as a monomer. We reported that ER binds EREs with a stoichiometry of two molecules of E2-bound ER per ERE, indicating that ER binds EREs as a homodimer (39–41,54,55). Thus, the stoichiometry of ER–ERE binding is 2:1. However, another group reported that 1 mol of ER is bound to 1 mol of ERE, rather than the expected stoichiometry of 2 ER/ERE as would be predicted if ER binds an ERE as a homodimer (56). The authors postulated that active ER is a monomer or heterodimer, but not a homodimer (56). However, recent studies of ER interaction with the lactoferrin promoter which contains an SF-1 response element (SFRE) 26 bp upstream of an imperfect ERE (sequence in Table 1) indicate that one ER dimer binds the SFRE (57). The authors postulated that one ER monomer binds the core element and the other monomer anchors on the surrounding sequence for stabilization (57). Similarly, ER bound as a homodimer to an SFRE (58), to ERE half-site regions within the rat prolactin gene promoter (59), and to the imperfect ERE in the pS2 gene (60).
|
ROLE OF PHOSPHORYLATION IN ER–ERE BINDING |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
All the steroid receptors, including ER
(61), are phosphorylated after binding their respective ligands (reviewed in 62). In addition, ER and ERß can be phosphorylated and activated in the absence of ligand binding (63–68). Phosphorylation of ER increases ER–ERE binding in vitro (61,62,69), although the effects of phosphorylation on the affinity of ER–ERE binding have not been determined.
EFFECT OF HIGH MOBILITY GROUP (HMG) PROTEINS 1 AND 2 ON ER–DNA BINDING
HMG domain proteins are architectural proteins involved in chromatin function (70). HMG-1 and HMG-2 have been shown to stabilize ER–ERE binding by decreasing the rate of ER–ERE dissociation (71–74). HMG-1 increased the affinity of baculovirus-expressed recombinant human (rh) ER binding from 10 to 0.25 nM as detected by electrophoretic mobility shift assay (EMSA) (74). HMG-1 also facilitates the binding of PR to PREs (75). HMG-1 and HMG-2 are thought to facilitate ER–ERE binding by inducing structural changes in the target DNA that enhance ER–ERE binding. HMG-1 also enhanced transcriptional activation by ER in transfected HeLa cells and enhanced the agonist activity of 4-OHT in MDA-MB-231 cells transfected with rhER (74). Together these results indicate that HMG-1 and HMG-2 play roles in stabilizing ER–ERE binding and in transcriptional activation, perhaps through mediating assembly of nucleoprotein complexes (76) and chromatin decondensation (reviewed in 77).
|
EFFECT OF LIGAND ON ER–ERE BINDING |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
The reported effect of ligand on ER–ERE binding affinity varies depending on the source and purity of ER and the method used to quantitate binding affinity. Ligand binding is required for maximal ER
–ERE binding in vivo, but not in vitro (78). However, ligand stabilizes ER–ERE binding (79). Additionally, although unliganded ER binds EREs in vitro, ligand binding affects the migration of the ER–ERE complex in EMSA experiments, indicating a role for ligand in altering ER conformation, as anticipated from crystal structure studies (80–83).
Recent anisotropic measurements using purified, baculovirus-expressed recombinant human ER and a 35 bp ERE oligomer (called F-ERE in Table S1) showed no effect of ligand, i.e. unoccupied or occupied with E2, ICI 182,780 or 4-OHT, on ER–ERE interaction in a buffer containing 200 mM KCl. These results, with those of other investigators, indicate that the effect of ligand on ER transactivation occurs at a step distal to ERE binding, e.g. promoting or inhibiting coactivator recruitment (reviewed in 6,84).
|
EFFECT OF NATURAL VARIATIONS IN ERE SEQUENCE ON ER BINDING AND TRANSCRIPTIONAL ACTIVATION |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
Most estrogen-regulated genes contain imperfect, non-palindromic EREs (21,45). Table 1 lists examples of 38 estrogen-responsive genes whose promoters or 3'UTRs contain functional EREs. This list also reports the affinity with which ER
and ERß interact with these EREs and the fold-induction of E2-stimulated reporter gene activity. These summary data indicate that ER binds the Xenopus vitellogenin A2 ERE with higher affinity than ERß and that the ER–ERß heterodimer binds with an affinity similar to that of ER rather than ERß. Overall, ER binds the Xenopus vitellogenin A2 ERE with higher affinity than any other natural ERE. Further, the data indicate that the more nucleotide changes there are from the consensus within a half-site of the ERE palindrome, the lower the ER binding affinity and the lower the transcriptional activity. We conclude that EREs in which nucleotides are altered in each arm of the palindrome show lower transcriptional activity than those containing alterations in only one half of the ERE palindrome. Experiments using synthetic and natural EREs confirm this conclusion (21,41,85–88). Additionally, these data indicate that the amount of transcriptional activation detected from the same ERE varies between cell types, indicating that cell-specific factors, e.g. the type and amount of coactivators, regulate ER transcriptional activation. In general, ER shows higher transcriptional activity than ERß (89).
One of the most widely studied estrogen-responsive genes is the PR and measurements of PR are used as a prognostic indicator in breast tumor samples. While long thought to be a primary estrogen-response gene, recent experiments suggest that PR may be indirectly activated by ER (90). Evidence for this suggestion comes from the observation that in Rat1 cells stably transfected with human ER containing a point mutation (Gly400 to Val400) (91), the time course of PR gene transcription did not parallel E2 binding to ER (90). Additionally, ER levels were decreased to 15% by 3 h and undetectable by 24 h, although PR gene transcription rate gradually increased over the 24 h of E2 treatment (90). Recent in vivo DNase I footprinting experiments indicate that ER interacts with an ERE half-site located 4 bp 5' to the first of two adjacent Sp1 binding sites in the promoter for PR-A (sequence in Table 1), and that ER increases Sp-1–DNA binding (92).
Flanking sequences impact ER–ERE binding (40,41,43–46,93) and transcriptional activation in vivo (24,25,85,86,94–96). A survey of genes whose transcription is highly upregulated by E2, e.g. the vitellogenins (Xenopus and chicken) and chicken apo-VLDLII, revealed that these genes contain an ERE in which the region flanking the ERE, but not overlapping the ERE, is AT-rich (44). For example, the most commonly used ERE palindrome from the Xenopus vitellogenin A2 gene has a 19 bp perfectly palindromic ERE and 14 of the next 20 nt immediately 5' flanking the ERE are either A or T (70% AT-rich) (36). While the mechanisms by which AT-rich DNA enhances transcriptional activity are unknown, the presence of AT-rich DNA flanking the ERE enhances ER binding affinity (24,39–41,43–46,55,85,95,97). One possible mechanism by which AT-rich DNA may affect ER activity is by altering DNA conformation. Regions of DNA enriched for AT nucleotides are more easily deformed compared to random DNA (98). Moreover, ER binding to an ERE results in a bend of the DNA toward the major groove (99,100) and AT-rich regions would enhance deformation. DNA bending is thought to facilitate interactions between components of the transcription complex bound to different sites (101).
|
EFFECT OF SYNTHETIC MUTATIONS IN ERE SEQUENCE ON ER BINDING AND TRANSCRIPTIONAL ACTIVATION |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
Early studies showed that mutations in each arm of the ERE palindrome decreased the efficiency of E2-dependent synergy between imperfect EREs (102). Screening of large libraries of degenerate oligonucleotides in a yeast-based screen was used to identify ER
-responsive sequences (103,104). Sequencing revealed that the majority of the identified sequences contained at least a 4/5 nucleotide match to a palindromic ERE half-site. Some contained half-sites arranged as direct repeats (DR) while some contained an ERE half-site plus an AT-rich sequence (104). A consensus septamer: 5'-GGTCAMV-3', where M is A or C and V is not T, was identified. Yeast-based screening of genomic DNA from MCF-7 cells identified a novel ERE that is a variant Alu sequence containing an imperfect ERE palindrome plus a perfect 3'ERE half-site located 9 bp 3' to the 3'ERE half-site in the ERE palindrome (see Alu ERE in Table S1) (103,104). Similar Alu ERE variants have been identified in the human BRCA1 gene (105) and ERß gene promoter (106). The affinity of ER binding to the yeast-screen identified EREs was not determined. Select EREs identified in the yeast screen were cloned into a luciferase reporter as 1, 2, 3, 4, 5 or 6 tandem copies. Whereas one copy of the Xenopus vitellogenin ERE gave a 29-fold induction in luciferase activity in response to 100 nM E2, the synthetic EREs resulted in 2.2–13-fold induction, indicating lower ER binding and transactivation (104). These results were the first hint that ER–ERE binding does not always result in a corresponding level of transcriptional activation.
Over the past 13 years we have investigated the effect of altering individual nucleotides within each arm or within both arms of the ERE palindrome on ER binding affinity by gel filtration chromatography (39,107), a microtiter plate assay in which the ER–ERE reaction was captured by histones fixed to the wells (40–42,44–46,54), DNase I footprinting (97) and EMSA (21,24,25). We also evaluated the effect of insertion or deletion of nucleotides from the 3 bp spacer. Table S1 shows the ERE sequences and results from these experiments. In summary, our data show that ER does not bind to ERE half-sites in which the palindrome is separated by 2, 4 or 5 bp. We have demonstrated that the length of the ERE palindrome is critical for high affinity ER–ERE binding. We observed that there is a 10-fold higher Kd for ER binding to EREc13 versus EREc15 (Table 1) (P.C.Kulakosky, S.C.Jernigan, M.A.McCarty and C.M.Klinge, manuscript submitted), indicating that the minimal ERE should be considered to be EREc15 and not EREc13 as earlier reported (37). In contrast to our expectations, further extension of the ERE palindrome by either 1 or 2 bp, generating EREc17 and EREc19 (Table S1), did not further increase affinity for either ER or ERß. It is noteworthy that the Xenopus vitellogenin A2 ERE palindrome is 19 bp in length (Table 1). Our data indicate that the ERE sequence providing the highest affinity for E2–ER binding is 5'-C(A/G)GGTCAnnnTGACC(T/C)G-3' (21; P.C.Kulakosky, S.C.Jernigan, M.A.McCarty and C.M.Klinge, manuscript submitted). These data are in agreement with data demonstrating the importance of the equivalent –7/+7 position in the GRE for dimeric GR binding (17) and in the PR response element (PRE) for PR binding (19). Other experiments demonstrated that the nucleotide composition of the 3 bp spacer as well as the –7 position in the GRE, PRE and AR response element (ARE) differentially impact the affinity of GR, PR and AR binding, thus yielding receptor-selective binding sites (20).
Recently, other investigators have employed fluorescence anisotropy to examine effects of variations in ERE sequence on ER–ERE binding kinetics (108). The synthetic ERE variants used in these studies contained two symmetric nucleotide changes in each arm of the ERE palindrome (see F-ERE mut sequences A–F in Table S1). The authors concluded that each of the base pairs in the palindromic ERE contributes significantly to ER binding affinity (108).
|
ER BINDING TO AN ERE HALF-SITE |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
While in theory one might anticipate that ER could bind to a single ERE half-site as a monomer, this probably does not occur in vivo because ER
readily forms stable dimers (109–113). Using EMSA, a microtiter plate ER–ERE binding assay and gel affinity chromatography we did not detect ER binding to a single half-site ERE (41,44–46,93,97). Similarly, others have not observed ER binding to a single ERE half-site (114) nor did ER footprint a single ERE half-site in the rainbow trout ER gene promoter (115). Recent studies using baculovirus-expressed recombinant mouse ER showed that one ER dimer binds to two half-site oligomers in EMSA with an affinity at least 20-fold lower than ER–ERE binding (59). Other studies suggest that ER binds to a single ERE half-site closely spaced with Sp1 binding sites in the presence of Sp1-DNA binding in the promoters of certain estrogen-regulated genes, e.g. hsp27 (116), TGFalpha (10), vitellogenin A1 io promoter (117) and PR (92). In conclusion, the data indicate that neither an ER monomer nor dimeric ER alone bind a single ERE half-site, but that dimeric ER can bind an ERE half-site when stabilized by protein–protein interactions with Sp1 bound to its GC-rich response element nearby in the promoter. |
ER BINDING TO DIRECT REPEAT (DR), INDIRECT REPEAT AND EVERTED REPEAT (EVR) SEQUENCES |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
DNA binding experiments have demonstrated that ER
binds DR of the ERE half-site 5'-AGGTCA-3', as well as ERE palindromes (118–120). A study of 5'-AGGTCA-3' DR spacing, i.e. DR1 (where 1 refers to the number of nucleotides separating half sites), DR2, DR3, DR4, DR5, DR10, DR15, DR20, DR25, DR35, DR50, DR100, DR150 and DR 200 showed that E2 stimulated transcription from all constructs in which the DR were separated by >10 bp in transiently transfected COS-1 cells (120). Although not noted by the authors, the spacer of constructs DR15 and greater contained an imperfect half-site 5'-CGGTCT-3', the significance of which is unknown. At best, E2-induced transcription 
6-fold from DR15 and DR20 compared to 19-fold from a perfectly palindromic ERE (120). DR separated by 35, 50, 100, 150 or 200 bp showed decreased E2-induced transcription (120). Another study reported that ER bound specifically to DR6, but 8–15-fold less retarded ER–DNA complex was formed on DR6 than on the ERE palindrome (121). In competition binding experiments, DR6 and a single ERE half-site competed for ER 6–10-fold less efficiently than the 13 bp palindromic ERE. A more recent study showed that neither ER nor ERß bound to DR1 or DR4, irrespective of the presence or absence of RXR (122). Thus, specific rules defining ER–DR binding, the affinity of such interaction, and the functional consequences of ER–DR binding, i.e. transcriptional responsiveness, remain to be clarified.
To that end, we recently determined the affinity of ER and ERß binding to synthetic DR5, DR11, DR16, DR21 and a DR16 construct in which the spacer region was AT-rich (called DR16AT) (88). ERß consistently bound DRs with a higher affinity than ER. Using the parameters of spacer length and the ratio of the length of the longest continuous AT-rich region within the spacer to the spacer length, we defined an equation by which the affinity of ER (equation 1) and ERß (equation 2) binding to DRs can be estimated:
LN (Kd) = [(0.55 x BPsubst) – (1.82 x HS) +3.11] ± 1.29 1
LN (Kd) = [(0.50 x BPsubst) – (1.48 x HS) +3.41] ± 1.17 2
where LN (Kd) is the natural logarithm of Kd, 1.29 and 1.17 are the standard errors of the predicted LN (Kd), HS is the number of half EREs (where half ERE is 5'-AGGTCA-3'); and BPsubst is the number of (AT)
(GC) substitutions in the ERE sequence (88). The number of half EREs and the number of (AT)(GC) base pair substitutions within the 15 bp candidate ERE sequence are statistically independent predictors of the affinity of ER–ERE interaction as described in these two equations (88).
When the ER DBD is expressed as a single molecule in which the two DBD monomers are joined by a peptide linker, the linker dimerized-ER DBD bound to an EVR separated by 15 bp, i.e. 5'-n11-TGACCT-n15-AGGTCA-n11-3' with a Kd of 100 nM, the consensus ERE with a Kd of 38 nM, and the pS2 imperfect ERE with a Kd of 110 nM (123). However, the linker dimerized ER did not bind to a DR15 sequence, i.e. 5'-n11-AGGTCA-n15-AGGTCA-n11-3' (123). These data indicate that the orientation of the half-sites determines the binding of the linker dimerized-ER.
In contrast to these reports showing ER binding to EVR and DR sequences, ER did not bind IR sequences, regardless of the number of base pairs separating the half-site, other than IR3 that is the same as a palindromic, consensus ERE (121). Similarly, ER did not bind to IR5, even in the presence of 3' flanking AT-rich nucleotides that increase ER–ERE binding (39).
|
EFFECT OF MULTIPLE TANDEM ERES ON ER BINDING AND TRANSCRIPTIONAL ACTIVATION |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
Early studies showed synergism, i.e. more than additive induction of reporter gene expression, for ER
bound to closely adjacent EREs and that the distance between the response elements was important in determining the amount of reporter gene induction (124). Transcriptional synergism from multiple EREs has been reported for ER (24,94,95,125,126). For both ER and ERß, we detected synergistic activation of reporter gene transcription from three tandem copies of EREc38 (sequence in Table S1), but not two copies of EREc38 (24,94). Synergy was independent of the distance of these EREs from the TATA box. These data correspond with the cooperative binding and higher affinity binding ER to three or four tandem copies of EREc38 versus one or two tandem copies of EREc38 (24,39,41,55). Although the exact mechanism for ER cooperative binding and transcriptional synergism is unknown, both the LBD and A/B domains are required (127). AF-1 is not required for transcriptional synergy from three or four tandem copies of EREc38, since both ER and ERß have similar fold-synergy, even though the absolute transcriptional activation by ERß is lower than ER (24).
Synergism also occurs for natural genes containing two EREs. The Xenopus vitellogenin B1 and B2 genes each contain two EREs, called the B1 estrogen responsive unit (ERU), that have low estrogen responsiveness alone, but act synergistically to achieve high estrogen inducibility (128). Analysis of ER binding to the B1 ERU revealed cooperative interaction of ER dimers with the two adjacent imperfect EREs which most likely explains the synergistic stimulation observed in vivo (129). ER bound cooperatively to the vitellogenin B1 ERE (52), substantiating a role for cooperative ER binding in transcriptional synergy.
The ‘rules’ of ERE spacing and synergistic transcriptional activation by ER are not yet defined because the available data do not indicate a correlation between ERE spacing and transcriptional activation. For example, comparison of the transcriptional activation of reporter gene activity in transiently transfected MCF-7 cells showed that two consensus EREs placed 6 or 19 bp apart were equally active (130). More experiments of this nature are needed to define how spacing between EREs impacts ER binding affinity and transactivation.
Transcriptional synergy from two or four tandem EREs has been reported to be cell-specific, i.e. functional synergism was detected in CHO cells transfected with hER, but not in XL-10, HepG2 or CTC-2 cells (125). This indicates a role for cellular factors, perhaps coactivators, in ER synergism at multiple EREs. ER bound cooperatively to an ERE consisting of two overlapping EREs separated by 5 bp (center-to-center, i.e. ‘overERE’ in Table S1) and synergistically activated reporter gene expression in transiently transfected HepG2 and MCF-7 cells (127). We reported cooperative ER binding to three or four, but not two tandem copies of a 38 bp consensus ERE, EREc38 in Table S1 (39–41,46,55). More recently we reported that three or four tandem copies of EREc38 synergistically activated reporter gene expression in transfected MCF-7, COS-1 and CHO-K1 cells transfected with ER or ERß (22,78,79). Although E2 treatment of CHO-K1 cells resulted in significantly lower induction of luciferase activity by ERß than by ER, there was no difference in the fold-synergy induced by ER or ERß (24). Synergy depends on the ligand bound to ER, implicating the LBD as well as the DBD in transcriptional synergy (24,85,94,95). Indeed our observation that ERß synergistically transactivates gene expression from multiple tandem EREs despite the fact that the N-terminal AF-1 domain of ERß is non-functional (131), indicates that AF-1 is not involved in functional synergy.
Transcriptional synergy may result from several possible mechanisms. These include cooperative recruitment of a coactivator(s), action at distinct rate-limiting steps in transcription initiation, cooperative ER–DNA binding (132), and/or direct protein–protein interactions between ER dimers. Also among the possible mechanisms for transcriptional synergism, ER may cause changes in DNA topology that are transmitted to another ER bound nearby. ER bends DNA (100,133). Thus, one may speculate that the distinct local topologies induced by binding of one ER dimer have differential allosteric effects on ER conformation and activity at adjacent sites. There are no reports as to whether ERß bends DNA. We and others have demonstrated that the stereoalignment of EREs on the DNA helix and their spacing influence synergistic responses to E2 (18,39–41,45,46,94,134). In yeast cells, changes in chromatin structure, protection of the EREs and hypermethylation in the flanking regions demonstrated that DNA binding of the ER per se promotes local changes in chromatin conformation in the absence of induced transcription (78), supporting a role for changes in DNA topology in transcriptional synergy. Further experiments are required to examine these potential mechanisms for transcriptional synergy.
|
QUANTITATIVE COMPARISON OF ER–ERE BINDING AFFINITY AND TRANSCRIPTIONAL ACTIVATION |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
Few investigators have examined the relationship of ER
–ERE binding affinity and transcriptional activation. The data in Table 1 reveal that these parameters have been determined for only seven natural estrogen-responsive genes. Figure 1 compares the transcriptional activity and affinity (Kd) of E2–ER for Xenopus and chicken vitellogenin A1, Xenopus vitellogenin B1 ERE2, human cathepsin D, rat cJun, human pS2 and mouse cFos 3'ERE. There is a good correlation between ERE binding affinity and transcriptional activation for these EREs, especially since, as indicated in Table 1, these data are from various laboratories using different experimental techniques. For ERß, we measured binding affinity and transcriptional activation for the Xenopus vitellogenin A1, human pS2, human Fos and human PR EREs and observed a correlation between Kd and reporter gene activation with EREs binding ERß with a Kd < 80 nM (88).
|
For synthetic EREs (Table S1), both ER
–ERE binding affinity and transcriptional activation have been determined for seven EREs. Comparison of the transcriptional activity and affinity (Kd) of E2–ER or E2–ERß for EREc13, EREc15, EREc19, EREc17,4, EREc17,6, EREc17,11 and EREc38 (sequences in Table S1) indicated no significant correlation between ER–ERE binding affinity and E2-induced transcriptional activation. The limited data available indicate the need for further experiments to clarify the relationship between ER binding affinity and transcriptional activation. |
CONCLUSIONS AND PROPOSED GUIDELINES FOR ER–ERE BINDING AND TRANSCRIPTIONAL ACTIVATION |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
A limitation of our understanding of the effect of ERE sequence on ER binding and transcriptional activation stems from the limitations of the assay methods used, e.g. measurements of ER binding to ‘naked’ DNA and transient transfection in mammalian cells. Since EREs are usually located in gene promoters containing multiple response elements for different transcription factors, the next logical step will be to examine ER interaction and transactivation from different gene promoters.
Table 2 presents a summary of nucleotide changes that have been studied in the consensus ERE and how these changes affect ER binding and/or transcriptional activation. Positions +2, +3 and +6 are identical for all vertebrate steroid hormone receptors; positions +4 and +5 differ and form the basis for discrimination between a GRE/PRE/ARE and an ERE. In earlier work, we proposed that ER binding requires that at least 10 of the 12 nt located between 2 and 7 nt from the center of the ERE IR, i.e. from –7 to +7 in Table 2, must be of the consensus sequence (21). Others reported that ER cannot accommodate a T in position –3 or +3 (49). Others proposed that position +6/–6 is important exclusively for the GRE/PRE family whereas position –3/+3 of an ERE can accommodate a C, T or G in one half-site within the palindrome or even a C in both halves, but a symmetric change to T prohibits ER binding (49).
|
The data in Table 2 suggest additional guidelines for ER–ERE binding: two nucleotide changes, one in each arm of the palindrome at whatever position, even if the change results in a palindrome, inhibit ER
binding, resulting in reduced ER binding affinity. Further, one or two nucleotide changes in one half-site decrease ER binding affinity even in the presence of a perfect ERE half-site in the imperfect palindrome.
Review of data from our own laboratory and those in the literature indicate that ER binding affinity does not always relate linearly with E2-induced transcriptional activation. While we detected a correlation between ER binding affinity and fold-induction of reporter gene activity with natural EREs (Fig. 1), no correlation was detected for synthetic mutant EREs. We suggest that the reasons for this discord are manifold and include the distance between the response element and the transcription start site (18); cellular amounts and roles for other transcription factors, coactivators and adaptor proteins both in ER binding and transcriptional activation (6); phosphorylation of ER and other proteins involved in transcriptional activation (62,135); and sequence-specific and protein-induced alterations in chromatin architecture (78). Clearly, additional experiments are needed to fully dissect the molecular mechanisms by which the transcriptional apparatus mitigates sequence-specific differences in ER–ERE binding affinities. In that regard, we speculate that different sets of coactivator proteins may be recruited to the unique ERE-containing enhancesome sequences in estrogen-regulated genes.
|
SUPPLEMENTARY MATERIAL |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
Table S1 is available as Supplementary Material at NAR Online.
|
FOOTNOTES |
|---|
* Tel: +1 502 852 3668; Fax: +1 502 852 6222; Email: carolyn.klinge{at}louisville.edu
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONSTRUCTURAL DOMAINS OF ER{alpha}...ER INTERACTION WITH EREsROLE OF PHOSPHORYLATION IN...EFFECT OF LIGAND ON...EFFECT OF NATURAL VARIATIONS...EFFECT OF SYNTHETIC MUTATIONS...ER BINDING TO AN...ER BINDING TO DIRECT...EFFECT OF MULTIPLE TANDEM...QUANTITATIVE COMPARISON OF ER...CONCLUSIONS AND PROPOSED...SUPPLEMENTARY MATERIALREFERENCES |
|---|
-
1 Lander,E.S., Linton,L.M., Birren,B., Nusbaum,C., Zody,M.C., Baldwin,J., Devon,K., Dewar,K., Doyle,M., FitzHugh,W. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860–921.[Medline]
2 Mangelsdorf,D.J., Thummel,C., Beato,M., Herrlich,P., Schutz,G., Umesono,K., Blumberg,B., Kastner,P., Mark,M., Chambon,P. and Evans,R.M. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835–839.[Web of Science][Medline]
3 Couse,J.F. and Korach,K.S. (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev., 20, 358–417.
4 Klinge,C.M., Brolly,C.L., Bambara,R.A. and Hilf,R. (1997) Hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro. J. Steroid Biochem. Mol. Biol., 63, 283–301.[Web of Science][Medline]
5 Devin-Leclerc,J., Meng,X., Delahaye,F., Leclerc,P., Baulieu,E.E. and Catelli,M.G. (1998) Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm. Mol. Endocrinol., 12, 842–854.
6 Klinge,C.M. (2000) Estrogen receptor interaction with co-activators and co-repressors. Steroids, 65, 227–251.[Web of Science][Medline]
7 Scholz,A., Truss,M. and Beato,M. (1998) Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium. J. Biol. Chem., 273, 4360–4366.
8 Rishi,A.K., Shao,Z.M., Baumann,R.G., Li,X.S., Sheikh,M.S., Kimura,S., Bashirelahi,N. and Fontana,J.A. (1995) Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res., 55, 4999–5006.
9 Qin,C., Singh,P. and Safe,S. (1999) Transcriptional activation of insulin-like growth factor-binding protein-4 by 17ß-estradiol in MCF-7 cells: role of estrogen receptor–Sp1 complexes. Endocrinology, 140, 2501–2508.
10 Vyhlidal,C., Samudio,I., Kladde,M.P. and Safe,S. (2000) Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J. Mol. Endocrinol., 24, 329–338.[Abstract]
11 Dong,L., Wang,W., Wang,F., Stoner,M., Reed,J.C., Harigai,M., Samudio,I., Kladde,M.P., Vyhlidal,C. and Safe,S. (1999) Mechanisms of transcriptional activation of bcl-2 gene expression by 17ß-estradiol in breast cancer cells. J. Biol. Chem., 274, 32099–32107.
12 Li,C., Briggs,M.R., Ahlborn,T.E., Kraemer,F.B. and Liu,J. (2001) Requirement of Sp1 and estrogen receptor alpha interaction in 17ß-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology, 142, 1546–1553.
13 Xing,W. and Archer,T.K. (1998) Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol. Endocrinol., 12, 1310–1321.
14 Webb,P., Lopez,G.N., Uht,R.M. and Kushner,P.J. (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway. Mol. Endocrinol., 9, 443–456.
15 Webb,P., Nguyen,P., Valentine,C., Lopez,G.N., Kwok,G.R., McInerney,E., Katzenellenbogen,B.S., Enmark,E., Gustafsson,J.A., Nilsson,S. and Kushner,P.J. (1999) The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol., 13, 1672–1685.
16 Paech,K., Webb,P., Kuiper,G.G., Nilsson,S., Gustafsson,J., Kushner,P.J. and Scanlan,T.S. (1997) Differential ligand activation of estrogen receptors ER and ERß at AP1 sites. Science, 277, 1508–1510.
17 Nordeen,S.K., Suh,B.J., Kuhnel,B. and Hutchison,C.D. (1990) Structural determinants of a glucocorticoid receptor recognition element. Mol. Endocrinol., 4, 1866–1873.
18 Nordeen,S.K., Ogden,C.A., Taraseviciene,L. and Lieberman,B.A. (1998) Extreme position dependence of a canonical hormone response element. Mol. Endocrinol., 12, 891–898.
19 Lieberman,B.A., Bona,B.J., Edwards,D.P. and Nordeen,S.K. (1993) The constitution of a progesterone response element. Mol. Endocrinol., 7, 515–527.
20 Nelson,C.C., Hendy,S.C., Shukin,R.J., Cheng,H., Bruchovsky,N., Koop,B.F. and Rennie,P.S. (1999) Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol. Endocrinol., 13, 2090–2107.
21 Driscoll,M.D., Sathya,G., Muyan,M., Klinge,C.M., Hilf,R. and Bambara,R.A. (1998) Sequence requirements for estrogen receptor binding to estrogen response elements. J. Biol. Chem., 273, 29321–29330.
22 Jones,P.S., Parrott,E. and White,I.N. (1999) Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent. J. Biol. Chem., 274, 32008–32014.
23 Hall,J.M. and McDonnell,D.P. (1999) The estrogen receptor beta-isoform (ERß) of the human estrogen receptor modulates ER transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology, 140, 5566–5578.
24 Tyulmenkov,V.T., Jernigan,S.C. and Klinge,C.M. (2000) Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements. Mol. Cell. Endocrinol., 165, 151–161.[Web of Science][Medline]
25 Tyulmenkov,V.T. and Klinge,C.M. (2000) Selectivity of detection of estrogen receptors and ß with cognate antibodies in electrophoretic mobility shift assay. Steroids, 65, 505–512.[Web of Science][Medline]
26 Cowley,S.M. and Parker,M.G. (1999) A comparison of transcriptional activation by ER alpha and ER beta. J. Steroid Biochem. Mol. Biol., 69, 165–175.[Web of Science][Medline]
27 Beato,M., Chalepakis,G., Schauer,M. and Slater,E.P. (1989) DNA regulatory elements for steroid hormones. J. Steroid. Biochem., 32, 737–747.[Web of Science][Medline]
28 Klein-Hitpass,L., Schorpp,M., Wagner,U. and Ryffel,G.U. (1986) An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell, 46, 1053–1061.[Web of Science][Medline]
29 Glass,C.K., Rosenfeld,M.G., Rose,D.W., Kurokawa,R., Kamei,Y., Xu,L., Torchia,J., Ogliastro,M.H. and Westin,S. (1997) Mechanisms of transcriptional activation by retinoic acid receptors. Biochem. Soc. Trans., 25, 602–605.[Web of Science][Medline]
30 Blumberg,B. and Evans,R.M. (1998) Orphan nuclear receptors-new ligands and new possibilities. Genes Dev., 12, 3149–3155.
31 Ogawa,S., Inoue,S., Watanabe,T., Hiroi,H. and Orimao,A. (1998) The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem. Biophys. Res. Commun., 243, 122–126.[Web of Science][Medline]
32 Kuiper,G.G., Shughrue,P.J., Merchenthaler,I. and Gustafsson,J.A. (1998) The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front. Neuroendocrinol., 19, 253–286.[Web of Science][Medline]
33 Montano,M.M., Muller,V., Trogaugh,A. and Katzenellenbogen,B.S. (1995) The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol., 9, 814–825.
34 Kuiper,G.G., Carlsson,B., Grandien,J., Enmark,E., Haggblad,J., Nilsson,S. and Gustafsson,J.-A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and ß. Endocrinology, 138, 863–870.
35 Green,S. and Chambon,P. (1987) Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature, 325, 75–78.[Medline]
36 Walker,P., Germond,J.E., Brown-Luedi,M., Givel,F. and Wahli,W. (1984) Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDL II genes. Nucleic Acids Res., 12, 8611–8626.
37 Klein-Hitpass,L., Ryffel,G.U., Heitlinger,E. and Cato,A.C. (1988) A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res., 16, 647–663.
38 Klock,G., Strahle,U. and Schutz,G. (1987) Oestrogen and glucocorticoid responsive elements are closely related but distinct. Nature, 329, 734–736.[Medline]
39 Klinge,C.M., Peale,F.V.,Jr, Hilf,R., Bambara,R.A. and Zain,S. (1992) Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res., 52, 1073–1081.
40 Klinge,C.M., Bambara,R.A. and Hilf,R. (1992) Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro. J. Steroid Biochem. Mol. Biol., 43, 249–262.[Web of Science][Medline]
41 Klinge,C.M., Traish,A.M., Bambara,R.A. and Hilf,R. (1996) Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor when the receptor binds estrogen response element DNA. J. Steroid Biochem. Mol. Biol., 57, 51–66.[Web of Science][Medline]
42 Klinge,C.M., Traish,A.M., Driscoll,M.D., Hilf,R. and Bambara,R.A. (1996) Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro. Steroids, 61, 278–289.[Web of Science][Medline]
43 Klinge,C.M., Bodenner,D.L., Desai,D., Niles,R.M. and Traish,A.M. (1997) Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro. Nucleic Acids Res., 25, 1903–1912.
44 Anolik,J.H., Klinge,C.M., Bambara,R.A. and Hilf,R. (1993) Differential impact of flanking sequences on estradiol- versus 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. J. Steroid Biochem. Mol. Biol., 46, 713–730.[Web of Science][Medline]
45 Anolik,J.H., Klinge,C.M., Hilf,R. and Bambara,R.A. (1995) Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry, 34, 2511–2520.[Medline]
46 Anolik,J.H., Klinge,C.M., Brolly,C.L., Bambara,R.A. and Hilf,R. (1996) Stability of the ligand of estrogen response element-bound estrogen receptor depends on flanking sequences and cellular factors. J. Steroid Biochem. Mol. Biol., 59, 413–429.[Web of Science][Medline]
47 Koszewski,N.J. and Notides,A.C. (1991) Phosphate-sensitive binding of the estrogen receptor to its response elements. Mol. Endocrinol., 5, 1129–1136.
48 Mader,S., Kumar,V., de Verneuil,H. and Chambon,P. (1989) Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature, 338, 271–274.[Medline]
49 Truss,M., Chalepakis,G., Slater,E.P., Mader,S. and Beato,M. (1991) Functional interaction of hybrid response elements with wild-type and mutant steroid hormone receptors. Mol. Cell. Biol., 11, 3247–3258.
50 Schwabe,J.W.R., Chapman,L., Finch,J.T. and Rhodes,D. (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell, 75, 567–578.[Web of Science][Medline]
51 Schwabe,J.W., Chapman,L. and Rhodes,D. (1995) The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. Structure, 3, 201–213.[Medline]
52 Martinez,E., Givel,F. and Wahli,W. (1989) Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J., 8, 3781–3791.[Web of Science][Medline]
53 Obourn,J.D., Koszewski,N.J. and Notides,A.C. (1993) Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor. Biochemistry, 32, 6229–6236.[Medline]
54 Ludwig,L.B., Peale,F.V.,Jr, Klinge,C.M., Bambara,R.A., Zain,S. and Hilf,R. (1990) A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements. Mol. Endocrinol., 4, 1027–1033.
55 Klinge,C.M., Studinski-Jones,A.L., Kulakosky,P.C., Bambara,R.A. and Hilf,R. (1998) Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Mol. Cell. Endocrinol., 143, 79–90.[Web of Science][Medline]
56 Furlow,J.D., Murdoch,F.E. and Gorski,J. (1993) High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J. Biol. Chem., 268, 12519–12525.
57 Zhang,Z. and Teng,C.T. (2000) Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J. Biol. Chem., 275, 20837–20846.
58 Vanacker,J.M., Pettersson,K., Gustafsson,J. and Laudet,V. (1999) Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta. EMBO J., 18, 4270–4279.[Web of Science][Medline]
59 Anderson,I. and Gorski,J. (2000) Estrogen receptor alpha interaction with estrogen response element half-sites from the rat prolactin gene. Biochemistry, 39, 3842–3847.[Medline]
60 Kim,J., Petz,L.N., Ziegler,Y.S., Wood,J.R., Potthoff,S.J. and Nardulli,A.M. (2000) Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol., 74, 157–168.[Web of Science][Medline]
61 Denton,R.R. and Notides,A.C. (1992) Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding. J. Biol. Chem., 267, 7263–7268.
62 Weigel,N.L. and Zhang,Y. (1998) Ligand-independent activation of steroid hormone receptors. J. Mol. Med., 76, 469–479.[Web of Science][Medline]
63 Power,R.F., Mani,S.K., Codina,J., Conneely,O.M. and O’Malley,B.W. (1991) Dopaminergic and ligand-independent activation of steroid hormone receptors. Science, 254, 1636–1639.
64 Pietras,R.J., Arboleda,J., Reese,D.M., Wongvipat,N., Pegram,M.D., Ramos,L., Gorman,C.M., Parker,M.G., Sliwkowski,M.Z. and Slamon,D.J. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435–2446.[Web of Science][Medline]
65 White,R., Sjoberg,M., Kalkhoven,E. and Parker,M.G. (1997) Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J., 16, 1427–1435.[Web of Science][Medline]
66 Tremblay,A., Tremblay,G.B., Labrie,F. and Giguere,V. (1999) Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell, 3, 513–519.[Web of Science][Medline]
67 Chen,D., Pace,P.E., Coombes,R.C. and Ali,S. (1999) Phosphorylation of human estrogen receptor by Protein Kinase A regulates dimerization. Mol. Cell. Biol., 19, 1002–1015.
68 Lamb,J., Ladha,M.H., McMahon,C., Sutherland,R.L. and Ewen,M.E. (2000) Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell. Biol., 20, 8667–8675.
69 Tzeng,D.Z. and Klinge,C.M. (1996) Phosphorylation of purified estradiol-liganded estrogen receptor by caseine kinase II increases estrogen response element binding but does not alter ligand stability. Biochem. Biophys. Res. Commun., 223, 554–560.[Web of Science][Medline]
70 Bustin,M. and Reeves,R. (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol., 54, 35–100.[Web of Science][Medline]
71 Edwards,D.P. (1997) The role of HMG proteins in steroid receptor action. Program Abstracts of the 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, Abstract #S16-2.
72 Romine,L.E., Wood,J.R., Lamia,L.A., Prendergast,P., Edwards,D.P. and Nardulli,A.M. (1998) The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol. Endocrinol., 12, 664–674.
73 Verrier,C.S., Bailey,L.R., Yee,C.J., Roodi,N., Jensen,R.A., Bustin,M. and Parl,F.F. (1995) The interaction of the estrogen receptor with its DNA response element is facilitated by the high mobility group protein, HMG-1. Protein Eng., 8, 78.
74 Zhang,C.C., Krieg,S. and Shapiro,D.J. (1999) HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol. Endocrinol., 13, 632–643.
75 Onate,S., Prendergast,P., Wagner,J.P., Nissen,M., Reeves,R., Pettijohn,D.E. and Edwards,D.P. (1994) The DNA-bending protein HMG-I enhances progesterone receptor binding to its target DNA sequences. Mol. Cell. Biol., 14, 3376–3391.
76 Boonyaratanakornkit,V., Melvin,V., Prendergast,P., Altmann,M., Ronfani,L., Bianchi,M.E., Taraseviciene,L., Nordeen,S.K., Allegretto,E.A. and Edwards,D.P. (1998) High-Mobility Group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell. Biol., 18, 4471–4487.
77 Ding,H.-F., Bustin,M. and Hansen,U. (1997) Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14. Mol. Cell. Biol., 17, 5843–5855.[Abstract]
78 Kladde,M.P., Xu,M. and Simpson,R.T. (1996) Direct study of DNA-protein interactions in repressed and active chromatin in living cells. EMBO J., 15, 6290–6300.[Web of Science][Medline]
79 Gronemeyer,H. (1991) Transcription activation by estrogen and progesterone receptors. Annu. Rev. Genet., 25, 89–123.[Web of Science][Medline]
80 Brzozowski,A.M., Pike,A.C., Dauter,Z., Hubbard,R.E., Bonn,T., Engstrom,O., Ohma,L., Greene,G.L., Gustafsson,J.A. and Carlquist,M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753–758.[Medline]
81 Tanenbaum,D.M., Wang,Y., Williams,S.P. and Sigler,P.B. (1998) Crystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains. Proc. Natl Acad. Sci. USA, 95, 5998–6003.
82 Shiau,A.K., Barstad,D., Loria,P.M., Cheng,L., Kushner,P.J., Agard,D.A. and Greene,G.L. (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell, 95, 927–37.[Web of Science][Medline]
83 Pike,A.C., Brzozowski,A.M., Hubbard,R.E., Bonn,T., Thorsell,A.G., Engstrom,O., Ljunggren,J., Gustafsson,J.A. and Carlquist,M. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J., 18, 4608–4618.[Web of Science][Medline]
84 Lanz,R.B., McKenna,N.J., Onate,S.A., Albrecht,U., Wong,J., Tsai,S.Y., Tsai,M.J. and O’Malley,B.W. (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell, 97, 17–27.[Web of Science][Medline]
85 Klinge,C.M. (1999) Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). J. Steroid Biochem. Mol. Biol., 71, 1–19.[Web of Science][Medline]
86 Klinge,C.M., Kaur,K. and Swanson,H.I. (2000) The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERR1. Arch. Biochem. Biophys., 373, 163–174.[Web of Science][Medline]
87 Klinge,C.M., Jernigan,S.C., Smith,S.L., Tyulmenkov,V.V. and Kulakosky,P.C. (2001) Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor . Mol. Cell. Endocrinol., in press.
88 Tyulmenkov,V.T. and Klinge,C.M. (2001) A mathematical approach to predict the affinity of estrogen receptors and ß binding to estrogen response elements, half-sites, and direct repeats. Mol. Cell. Endocrinol., in press.
89 Tremblay,G.B., Tremblay,A., Copeland,N.G., Gilbert,D.J., Jenkins,N.A., Labrie,F. and Giguere,V. (1997) Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor ß. Mol. Endocrinol., 11, 353–365.
90 Lee,Y.-J. and Gorski,J. (1996) Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc. Natl Acad. Sci. USA, 93, 15180–15184.
91 Kaneko,K.J., Gelinas,C. and Gorski,J. (1993) Activation of the silent progesterone receptor gene by ectopic expression of estrogen receptors in a rat fibroblast cell line. Biochemistry, 32, 8348–8359.[Medline]
92 Petz,L.N. and Nardulli,A.M. (2000) Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol. Endocrinol., 14, 972–985.
93 Klinge,C.M., Bambara,R.A. and Hilf,R. (1992) What differentiates antiestrogen-liganded versus estradiol-liganded estrogen receptor action? Oncology Res., 4, 1073–1081.
94 Sathya,G., Wenzhou,L., Klinge,C.M., Anolik,J.H., Hilf,R. and Bambara,R.A. (1997) Effects of multiple estrogen responsive elements, their spacing and location on estrogen response of reporter genes. Mol. Endocrinol., 11, 1994–2003.
95 Klinge,C.M. (1999) Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression. Mol. Cell. Endocrinol., 150, 99–111.[Web of Science][Medline]
96 Klinge,C.M., Bowers,J.L., Kulakosky,P.C., Kamboj,K.K. and Swanson,H.I. (1999) The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Mol. Cell. Endocrinol., 157, 105–119.[Web of Science][Medline]
97 Driscoll,M.D., Klinge,C.M., Hilf,R. and Bambara,R.A. (1996) Footprint analysis of estrogen receptor binding to adjacent estrogen response elements. J. Steroid Biochem. Mol. Biol., 58, 45–61.[Web of Science][Medline]
98 Wang,Y. and Sauerbier,W. (1989) AT-rich sequences may lower the activation energy of cruciform extrusion in supercoiled DNA. Biochem. Biophys. Res. Commun., 158, 423–431.[Web of Science][Medline]
99 Sabbah,M., Ricousse,S.L., Redeuilh,G. and Baulieu,E.E. (1992) Estrogen receptor-induced bending of the Xenopus vitellogenin A2 gene hormone response element. Biochem. Biophys. Res. Commun., 185, 944–952.[Web of Science][Medline]
100 Nardulli,A.M., Greene,G.L. and Shapiro,D.J. (1993) Human estrogen receptor bound to an estrogen response element bends DNA. Mol. Endocrinol., 7, 331–340.
101 Kerppola,T.K. and Curran,T. (1991) DNA bending by Fos and Jun: the flexible hinge model. Science, 254, 1210–1214.
102 Martinez,E., Givel,F. and Wahli,W. (1987) The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid responsive element. EMBO J., 6, 3719–3727.[Web of Science][Medline]
103 Nawaz,Z., Tsai,M.J., McDonnell,D.P. and O’Malley,B.W. (1992) Identification of novel steroid-response elements. Gene Expr., 2, 39–47.[Medline]
104 Dana,S.L., Hoener,P.A., Wheeler,D.A., Lawrence,C.B. and McDonnell,D.P. (1994) Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol. Endocrinol., 8, 1193–1207.
105 Xu,C.F., Chambers,J.A. and Solomon,E. (1997) Complex regulation of the BRCA1 gene. J. Biol. Chem., 272, 20994–20997.
106 Li,L.C., Yeh,C.C., Nojima,D. and Dahiya,R. (2000) Cloning and characterization of human estrogen receptor beta promoter. Biochem. Biophys. Res. Commun., 275, 682–689.[Web of Science][Medline]
107 Peale,F.V., Ludwig,L.B., Zain,S., Hilf,R. and Bambara,R.A. (1988) Properties of a high-affinity DNA binding site for estrogen receptor. Proc. Natl. Acad. Sci. USA, 85, 1038–1042.
108 Boyer,M., Poujol,N., Margeat,E. and Royer,C.A. (2000) Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy. Nucleic Acids Res., 28, 2494–2502.
109 Sasson,S. and Notides,A.C. (1983) Estriol and estrone interaction with the estrogen receptor. I. Temperature-induced modulation of the cooperative binding of [3H]estriol and [3H]estrone to the estrogen receptor. J. Biol. Chem., 258, 8113–8117.
110 Sasson,S. and Notides,A.C. (1983) Estriol and estrone interaction with the estrogen receptor. II. Estriol and estrone-induced inhibition of the cooperative binding of [3H]estradiol to the estrogen receptor. J. Biol. Chem., 258, 8118–8122.
111 Sasson,S. and Notides,A.C. (1984) Inability of [3H]estriol to induce maximal cooperativity of the estrogen receptor. J. Steroid Biochem., 20, 1027–1032.[Web of Science][Medline]
112 Sasson,S. and Notides,A.C. (1984) The estriol-induced inhibition of the estrogen receptor’s positive cooperativity. J. Steroid Biochem., 20, 1021–1026.[Web of Science][Medline]
113 Skafar,D.F. and Notides,A.C. (1985) Modulation of the estrogen receptor’s affinity for DNA by estradiol. J. Biol. Chem., 260, 12208–12213.
114 Kim,J., DeHaan,G., Nardulli,A.M. and Shapiro,D.J. (1997) Prebending the estrogen response element destabilized binding of the estrogen receptor DNA binding domain. Mol. Cell. Biol., 17, 3173–3180.[Abstract]
115 Lazennec,G., Kern,L., Salbert,G., Saligaut,D. and Valotaire,Y. (1996) Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter. Mol. Endocrinol., 10, 1116–1126.
116 Porter,W., Saville,B., Hoivik,D. and Safe,S. (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol., 11, 1569–1580.
117 de Medeiros,S.R.B., Krey,G., Hihi,A.K. and Wahli,W. (1997) Functional interactions between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter. J. Biol. Chem., 272, 18250–18260.
118 Mader,S., Leroy,P., Chen,J.Y. and Chambon,P. (1993) Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J. Biol. Chem., 268, 591–600.
119 Kato,S., Tora,L., Yamauchi,J., Masushige,S., Bellard,M. and Chambon,P. (1992) A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically. Cell, 68, 731–742.[Web of Science][Medline]
120 Kato,S., Sasaki,J.H., Suzawa,M., Masushige,S., Tora,L., Chambon,P. and Gronemeyer,H. (1995) Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol. Cell. Biol., 15, 5858–5867.[Abstract]
121 Aumais,J.P., Lee,H.S., DeGannes,C., Horsford,J. and White,J. (1996) Function of directly repeated half sites as response elements for steroid hormones. J. Biol. Chem., 271, 12568–12577.
122 Pettersson,K., Grandien,K., Kuiper,G.G.J.M. and Gustafsson,J.-A. (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol., 11, 1486–1496.
123 Kuntz,M.A. and Shapiro,D.J. (1997) Dimerizing the estrogen receptor DNA binding domain enhances binding to estrogen response elements. J. Biol. Chem., 272, 27949–27956.
124 Wahli,W. and Martinez,E. (1991) Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J., 5, 2243–2249.[Abstract]
125 Mattick,S., Glenn,K., deHaan,G. and Shapiro,D.J. (1997) Analysis of ligand dependence and hormone response element synergy in transcription by estrogen receptor. J. Steroid Biochem. Mol. Biol., 60, 285–294.[Web of Science][Medline]
126 de Haan,G., Chusacultanachai,S., Mao,C., Katzenellenbogen,B.S. and Shapiro,D.J. (2000) Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression. J. Biol. Chem., 275, 13493–13501.
127 Massaad,C., Coumoul,X., Sabbah,M., Garlatti,M., Redeuilh,G. and Barouki,R. (1998) Properties of overlapping EREs: synergistic activation of transcription and cooperative binding of ER. Biochemistry, 37, 6023–6032.[Medline]
128 Klein-Hitpass,L., Kaling,M. and Ryffel,G.U. (1988) Synergism of closely adjacent estrogen-responsive elements increases their regulatory potential. J. Mol. Biol., 210, 537–544.
129 Wahli,W., Martinez,E., Corthesy,B. and Cardinaux,J.R. (1989) Cis- and trans-acting elements of the estrogen-regulated vitellogenin gene B1 of Xenopus laevis. J. Steroid Biochem., 34, 17–32.[Web of Science][Medline]
130 VanderKuur,J.A., Hafner,M.S., Christman,J.K. and Brooks,S.C. (1993) Effects of estradiol-17 beta analogues on activation of estrogen response element regulated chloramphenicol acetyltransferase expression. Biochemistry, 32, 7016–7021.[Medline]
131 McInerney,E.M., Weis,K.E., Sun,J., Mosselman,S. and Katzenellenbogen,B.S. (1998) Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology, 139, 4513–4522.
132 Herschlag,D. and Johnson,F.B. (1993) Synergism in transcriptional activation: a kinetic view. Genes Dev., 7, 173–179.
133 Nardulli,A.M., Grobner,C. and Cotter,D. (1995) Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence. Mol. Endocrinol., 9, 1064–1076.
134 Ponglikitmongkol,M., White,J.H. and Chambon,P. (1990) Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. EMBO J., 9, 2221–2231.[Web of Science][Medline]
135 Weigel,N.L. (1996) Steroid hormone receptors and their regulation by phosphorylation. Biochem. J., 319, 657–667.
136 Augereau,P., Miralles,F., Cavailles,V., Gaudelet,C., Parker,M. and Rochefort,H. (1994) Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol., 8, 693–703.
137 Murdoch,F.E., Meier,D.A., Furlow,J.D., Grunwald,K.A. and Gorski,J. (1990) Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol. Biochemistry, 29, 8377–8385.[Medline]
138 Curtis,S.W. and Korach,K.S. (1991) Uterine estrogen receptor-DNA complexes: effects of different ERE sequences, ligands, and receptor forms. Mol. Endocrinol., 5, 959–966.
139 Aliau,S., Groblewski,T. and Borgna,J.L. (1995) The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA. Eur. J. Biochem., 231, 204–213.[Web of Science][Medline]
140 Carlsson,B. and Haggblad,J. (1995) Quantitative determination of DNA-binding parameters for the human estrogen receptor in a solid-phase, nonseparation assay. Anal. Biochem., 232, 172–179.[Web of Science][Medline]
141 Ozers,M.S., Hill,J.J., Ervin,K., Wood,J.R., Nardulli,A.M., Royer,C.A. and Gorski,J. (1997) Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy. J. Biol. Chem., 272, 30405–30411.
142 Nardulli,A.M., Romine,L., Carpo,C., Greene,G.L. and Rainish,B. (1996) Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol. Endocrinol., 10, 694–704.
143 Cowley,S.M., Hoare,S., Mosselman,S. and Parker,M.G. (1997) Estrogen receptors alpha and beta form heterodimers on DNA. J. Biol. Chem., 272, 19858–19862.
144 Hyder,S.M., Chiappetta,C. and Stancel,G.M. (1999) Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. [published erratum appears in Biochem. Pharmacol. (1999) 57, 1447] Biochem. Pharmacol., 57, 597–601.[Web of Science]
145 Ernst,M., Parker,M.G. and Rodan,G.A. (1991) Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol. Endocrinol., 5, 1597–1606.
146 Smith,C.L., Conneely,O.M. and O’Malley,B.W. (1993) Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc. Natl Acad. Sci. USA, 90, 6120–6124.
147 Berry,M., Nunez,A.M. and Chambon,P. (1989) Estrogen responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl Acad. Sci. USA, 86, 1218–1222.
148 Hyder,S.M., Stancel,G.M., Nawaz,Z., McDonnell,D.P. and Loose-Mitchell,D.S. (1992) Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. J. Biol. Chem., 267, 18047–18054.
149 Melamed,M., Arnold,S.F., Notides,A.C. and Sasson,S. (1996) Kinetic analysis of the interaction of human estrogen receptor with an estrogen response element. J. Steroid Biochem. Mol. Biol., 57, 153–159.[Web of Science][Medline]
150 Burbach,J.P.H., daSilva,S.L., Cox,J.J., Adan,R.A.H., Cooney,A. J., Tsai,M.-J. and Tsai,S.Y. (1994) Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. J. Biol. Chem., 269, 15046–15053.
151 Burch,J.B., Evans,M.I., Friedman,T.M. and O’Malley,P.J. (1988) Two functional estrogen response elements are located upstream of the major chicken vitellogenin gene. Mol. Cell. Biol., 8, 1123–1131.
152 Cato,A.C., Heitlinger,E., Ponta,H., Klein-Hitpass,L., Ryffel,G.U., Bailly,A., Rauch,C. and Milgrom,E. (1988) Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action. Mol. Cell. Biol., 8, 5323–5330.
153 Chang,T.C., Nardulli,A.M., Lew,D. and Shapiro,D.J. (1992) The role of estrogen response elements in expression of the Xenopus laevis vitellogenin B1 gene. Mol. Endocrinol., 6, 346–354.
154 Seiler-Tuyns,A., Walker,P., Martinez,E., Merillat,A.M., Givel,F. and Wahli,W. (1986) Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. Nucleic Acids Res., 14, 8755–8770.
155 Lee,J.H., Kim,J. and Shapiro,D.J. (1995) Regulation of Xenopus laevis estrogen receptor gene expression is mediated by an estrogen response element in the protein coding region. DNA Cell. Biol., 14, 419–430.[Web of Science][Medline]
156 Wijnholds,J., Philipsen,J.N. and Ab,G. (1988) Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apoVLDL II promoter in vivo. EMBO J., 7, 2757–2763.[Web of Science][Medline]
157 Gaub,M.P., Bellard,M., Scheuer,I., Chambon,P. and Sassone-Corsi,P. (1990) Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell, 63, 1267–1276.[Web of Science][Medline]
158 Tora,L., Gaub,M.P., Mader,S., Dierich,A., Bellard,M. and Chambon,P. (1988) Cell-specific activity of a GGTCA half-palindromic oestrogen-responsive element in the chicken ovalbumin gene promoter. EMBO J., 7, 3771–3778.[Web of Science][Medline]
159 Zhao,Y.Y., Zhou,J., Narayanan,C.S., Cui,Y. and Kumar,A. (1999) Role of C/A polymorphism at –20 on the expression of human angiotensinogen gene. Hypertension, 33, 108–115.
160 Perillo,B., Sasso,A., Abbondanza,C. and Palumbo,G. (2000) 17ß-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol., 20, 2890–2901.
161 Jeung,E.B., Leung,P.C. and Krisinger,J. (1994) The human calbindin-D9k gene. Complete structure and implications on steroid hormone regulation. J. Mol. Biol., 235, 1231–1238.[Web of Science][Medline]
162 Fan,J.D., Wagner,B.L. and McDonnell,D.P. (1996) Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol. Endocrinol., 10, 1605–1616.
163 Watanabe,T., Inoue,S., Hiroi,H., Orimo,A., Kawashima,H. and Muramatsu,M. (1998) Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol., 18, 442–449.
164 Inoue,S., Orimo,A., Hosoi,T., Kondo,S., Toyoshima,H., Kondo,T., Ikegami,A., Ouchi,Y., Orimo,H. and Muramatsu,M. (1993) Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc. Natl Acad. Sci. USA, 90, 11117–11121.
165 Orimo,A., Inoue,S., Minowa,O., Tominaga,N., Tomioka,Y., Sato,M., Kuno,J., Hiroi,H., Shimizu,Y., Suzuki,M., Noda,T. and Muramatsu,M. (1999) Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha. Proc. Natl Acad. Sci. USA, 96, 12027–12032.
166 Ikeda,K., Orimo,A., Higashi,Y., Muramatsu,M. and Inoue,S. (2000) Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett., 472, 9–13.[Web of Science][Medline]
167 Pethe,V. and Shekhar,P.V. (1999) Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J. Biol. Chem., 274, 30969–30978.
168 van Dijck,P. and Verhoeven,G. (1992) Interaction of estrogen receptor complexes with the promoter region of genes that are negatively regulated by estrogens: the alpha 2u-globulins. Biochem. Biophys. Res. Commun., 182, 174–181.[Web of Science][Medline]
169 Roy,A.K., McMinn,D.M. and Biswas,N.M. (1975) Estrogenic inhibition of the hepatic synthesis of alpha2u globulin in the rat. Endocrinology, 97, 1501–1508.
170 van Dijck,P., Schoonjans,K., Sassone-Corsi,P., Auwerx,J. and Verhoeven,G. (1993) A Fos-Jun element in the first intron of an alpha 2u-globulin gene. Mol. Cell. Biochem., 125, 127–136.[Web of Science][Medline]
171 van Dijck,P., De Vos,P., Winderickx,J. and Verhoeven,G. (1993) Multiple binding sites for nuclear factors in the 5'-upstream region of two alpha 2u-globulin genes: implications for hormone-regulated and tissue-specific control. J. Steroid Biochem. Mol. Biol., 45, 353–366.[Web of Science][Medline]
172 Teng,C.T., Liu,Y., Yang,N., Walmer,D. and Panella,T. (1992) Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse. Mol. Endocrinol., 6, 1969–1981.
173 Kastner,P., Krust,A., Turcotte,B., Stropp,U., Tora,L., Gronemeyer,H. and Chambon,P. (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J., 9, 1603–1614.[Web of Science][Medline]
174 Kraus,W.L., Montano,M.M. and Katzenellenbogen,B.S. (1994) Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol. Endocrinol., 8, 952–969.
175 Cheung,J. and Smith,D.F. (2000) Molecular chaperone interactions with steroid receptors: an update. Mol. Endocrinol., 14, 939–946.
176 Montano,M.M., Jaiswal,A.K. and Katzenellenbogen,B.S. (1998) Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J. Biol. Chem., 273, 25443–25449.
177 Mueller,M.D., Vigne,J.L., Minchenko,A., Lebovic,D.I., Leitman,D.C. and Taylor,R.N. (2000) Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc. Natl Acad. Sci. USA, 97, 10972–10977.
178 Norris,J.D., Fan,D., Aleman,C., Marks,J.R., Futreal,P.A., Wiseman,R.W., Iglehart,J.D., Deininger,P.L. and McDonnell,D.P. (1995) Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J. Biol. Chem., 270, 22777–22782.
179 L’Horset,F., Blin,C., Colnot,S., Lambert,M., Thomasset,M. and Perret,C. (1994) Calbindin-D9k gene expression in the uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element. Endocrinology, 134, 11–18.
180 Wu-Peng,S.X., Pugliese,T.E., Dickerman,H.W. and Pentecost,B.T. (1992) Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol. Endocrinol., 6, 231–240.
181 Castro-Rivera,E., Wormke,M. and Safe,S. (1999) Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells. Mol. Cell. Endocrinol., 150, 11–21.[Web of Science][Medline]
182 Krawczyk,Z., Schmid,W., Harkonen,P. and Wolnirzek,P. (1992) The ERE-like sequence from the promoter region of the testis specific hsp70-related gene is not estrogen responsive. Cell Biol. Int. Rep., 16, 937–948.[Web of Science][Medline]
183 Krawczyk,Z., Schmid,W., Harkonen,P. and Wolniczek,P. (1993) The ERE-like sequence from the promoter region of the testis specific hsp70-related gene is not estrogen responsive. Cell Biol. Int., 17, 245–253.[Web of Science][Medline]
184 Shupnik,M.A., Weinmann,C.M., Notides,A.C. and Chin,W.W. (1989) An upstream region of the rat luteinizing hormone beta gene binds estrogen receptor and confers estrogen responsiveness. J. Biol. Chem., 264, 80–86.
185 Hyder,S.M., Nawaz,Z., Chiappetta,C., Yokoyama,K. and Stancel,G.M. (1995) The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J. Biol. Chem., 270, 8506–8513.
186 Maurer,R.A. (1985) Selective binding of the estradiol receptor to a region at least one kilobase upstream from the rat prolactin gene. DNA, 4, 1–9.[Web of Science][Medline]
187 Maurer,R.A. and Notides,A.C. (1987) Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin gene. Mol. Cell. Biol., 7, 4247–4254.
188 Murdoch,F.E., Byrne,L.M., Ariazi,E.A., Furlow,J.D., Meier,D.A. and Gorski,J. (1995) Estrogen receptor binding to DNA: affinity for nonpalindromic elements from the rat prolactin gene. Biochemistry, 34, 9144–9150.[Medline]
189 Berwaer,M., Monget,P., Peers,B., Mathy-Hartert,M., Bellefroid,E., Davis,J.R., Belayew,A. and Martial,J.A. (1991) Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol. Cell. Endocrinol., 80, 53–64.[Web of Science][Medline]
190 Shapiro,R.A., Xu,C. and Dorsa,D.M. (2000) Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta. Endocrinology, 141, 4056–4064.
191 Hyder,S.M., Nawaz,Z., Chiappetta,C. and Stancel,G.M. (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res., 60, 3183–3190.
192 Hyder,S.M., Stancel,G.M. and Loose-Mitchell,D.S. (1991) Presence of an estradiol response region in the mouse c-fos oncogene. Steroids, 56, 498–504.[Web of Science][Medline]
193 Takahashi,K., Sendai,Y., Matsuda,Y., Hoshi,H., Hiroi,M. and Araki,Y. (2000) Mouse oviduct-specific glycoprotein gene: genomic organization and structure of the 5'-flanking regulatory region. Biol. Reprod., 62, 217–226.
194 Lopez de Haro,M.S., Garcia,C. and Nieto,A. (1990) Localization of an estrogen receptor binding site near the promoter of the uteroglobin gene. FEBS Lett., 265, 20–22.[Web of Science][Medline]
195 Slater,E.P., Redeuihl,G., Theis,K., Suske,G. and Beato,M. (1990) The uteroglobin promoter contains a noncanonical estrogen responsive element. Mol. Endocrinol., 4, 604–610.
196 Komatsu,K., Oeda,T. and Strott,C.A. (1993) Cloning and sequence analysis of the 5'-flanking region of the estrogen sulfotransferase gene: steroid response elements and cell-specific nuclear DNA-binding proteins. Biochem. Biophys. Res. Commun., 194, 1297–1304.[Web of Science][Medline]
197 Kumar,V. and Chambon,P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell, 55, 145–156.[Web of Science][Medline]
198 Murdoch,F.E., Grunwald,K.A.A. and Gorski,J. (1991) Marked effects of salt on estrogen receptor binding to DNA. Biochemistry, 30, 10838–10844.[Medline]
199 Metzger,D., White,J.H. and Chambon,P. (1988) The human oestrogen receptor functions in yeast. Nature, 334, 31–36.[Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. L. Nott, Y. Huang, X. Li, B. R. Fluharty, X. Qiu, W. V. Welshons, S. Yeh, and M. Muyan Genomic Responses from the Estrogen-responsive Element-dependent Signaling Pathway Mediated by Estrogen Receptor {alpha} Are Required to Elicit Cellular Alterations J. Biol. Chem., May 29, 2009; 284(22): 15277 - 15288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Matagne, C. Mastronardi, R. A. Shapiro, D. M. Dorsa, and S. R. Ojeda Hypothalamic Expression of Eap1 Is Not Directly Controlled by Ovarian Steroids Endocrinology, April 1, 2009; 150(4): 1870 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Keay and J. W. Thornton Hormone-Activated Estrogen Receptors in Annelid Invertebrates: Implications for Evolution and Endocrine Disruption Endocrinology, April 1, 2009; 150(4): 1731 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Y. Choi, Q. T. Gao, A. W. H. Cheung, J. T. T. Zhu, F. T. C. Lau, J. Li, W. Z. M. Li, G. K. Y. Chu, R. Duan, J. K. H. Cheung, et al. A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation Evid. Based Complement. Altern. Med., January 8, 2009; (2009) nen085v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. F. Pan, K. D. S. A. Wansa, M. H. Liu, B. Zhao, S. Z. Hong, P. Y. Tan, K. S. Lim, G. Bourque, E. T. Liu, and E. Cheung Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements J. Biol. Chem., November 21, 2008; 283(47): 32977 - 32988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wu, R. Xu, K. Kim, J. Martin, and S. Safe In Vivo Profiling of Estrogen Receptor/Specificity Protein-Dependent Transactivation Endocrinology, November 1, 2008; 149(11): 5696 - 5705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Holmes, J. S. Song, X. S. Liu, M. Brown, and J. S. Carroll Nkx3-1 and LEF-1 Function as Transcriptional Inhibitors of Estrogen Receptor Activity Cancer Res., September 15, 2008; 68(18): 7380 - 7385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Chen, M.-T. Lee, H.-C. Yao, P.-W. Hsiao, F.-C. Ke, and J.-J. Hwang Crucial Role of Estrogen Receptor-{alpha} Interaction with Transcription Coregulators in Follicle-Stimulating Hormone and Transforming Growth Factor {beta}1 Up-Regulation of Steroidogenesis in Rat Ovarian Granulosa Cells Endocrinology, September 1, 2008; 149(9): 4658 - 4668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Han, L. Yang, F. Suarez-Saiz, S. San-Marina, J. Cui, and M. D. Minden Wilms' Tumor 1 Suppressor Gene Mediates Antiestrogen Resistance via Down-Regulation of Estrogen Receptor-{alpha} Expression in Breast Cancer Cells Mol. Cancer Res., August 1, 2008; 6(8): 1347 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Raulic, Y. Ramos-Valdes, and G. E DiMattia Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro J. Endocrinol., June 1, 2008; 197(3): 517 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. M. Herrera, P. Bagamasbad, T. Didishvili, J. L. Decano, and N. Ruiz-Opazo Overlapping genes in Nalp6/PYPAF5 locus encode two V2-type vasopressin isoreceptors: angiotensin-vasopressin receptor (AVR) and non-AVR Physiol Genomics, June 1, 2008; 34(1): 65 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mao, N. M. Patterson, M. T. Cherian, I. O. Aninye, C. Zhang, J. B. Montoya, J. Cheng, K. S. Putt, P. J. Hergenrother, E. M. Wilson, et al. A New Small Molecule Inhibitor of Estrogen Receptor {alpha} Binding to Estrogen Response Elements Blocks Estrogen-dependent Growth of Cancer Cells J. Biol. Chem., May 9, 2008; 283(19): 12819 - 12830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Arpino, L. Wiechmann, C. K. Osborne, and R. Schiff Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance Endocr. Rev., April 1, 2008; 29(2): 217 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Mattingly, M. M. Ivanova, K. A. Riggs, N. S. Wickramasinghe, M. J. Barch, and C. M. Klinge Estradiol Stimulates Transcription of Nuclear Respiratory Factor-1 and Increases Mitochondrial Biogenesis Mol. Endocrinol., March 1, 2008; 22(3): 609 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kimura, N. Takamatsu, Y. Yaoita, R Y. Osamura, and N. Kimura Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation J. Mol. Endocrinol., February 1, 2008; 40(2): 75 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kapoor and J. J. Sheng Transfection of Human Prostate Cancer CA-HPV-10 Cells with Cytosolic Sulfotransferase SULT1E1 Affects Estrogen Signaling and Gene Transcription Drug Metab. Dispos., February 1, 2008; 36(2): 316 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Adamson, S. Friedrichsen, S. Semprini, C. V. Harper, J. J. Mullins, M. R. H. White, and J. R. E. Davis Human Prolactin Gene Promoter Regulation by Estrogen: Convergence with Tumor Necrosis Factor-{alpha} Signaling Endocrinology, February 1, 2008; 149(2): 687 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bourdeau, J. Deschenes, D. Laperriere, M. Aid, J. H. White, and S. Mader Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells Nucleic Acids Res., January 17, 2008; 36(1): 76 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Frietze, M. Lupien, P. A. Silver, and M. Brown CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-regulation of E2F1 Cancer Res., January 1, 2008; 68(1): 301 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gao, S. Falt, A. Sandelin, J.-A. Gustafsson, and K. Dahlman-Wright Genome-Wide Identification of Estrogen Receptor {alpha}-Binding Sites in Mouse Liver Mol. Endocrinol., January 1, 2008; 22(1): 10 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Boverhof, L. D. Burgoon, K. J. Williams, and T. R. Zacharewski Inhibition of Estrogen-Mediated Uterine Gene Expression Responses by Dioxin Mol. Pharmacol., January 1, 2008; 73(1): 82 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sun, Z. Nawaz, and J. M. Slingerland Long-Range Activation of GREB1 by Estrogen Receptor via Three Distal Consensus Estrogen-Responsive Elements in Breast Cancer Cells Mol. Endocrinol., November 1, 2007; 21(11): 2651 - 2662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Higashi, T. Fukami, M. Itoh, S. Kyo, M. Inoue, T. Yokoi, and M. Nakajima Human CYP2A6 Is Induced by Estrogen via Estrogen Receptor Drug Metab. Dispos., October 1, 2007; 35(10): 1935 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Grisouard, S. Medunjanin, A. Hermani, A. Shukla, and D. Mayer Glycogen Synthase Kinase-3 Protects Estrogen Receptor {alpha} from Proteasomal Degradation and Is Required for Full Transcriptional Activity of the Receptor Mol. Endocrinol., October 1, 2007; 21(10): 2427 - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kundu, A. Alioua, E. Stefani, and L. Toro Regulation of Mouse Slo Gene Expression: MULTIPLE PROMOTERS, TRANSCRIPTION START SITES, AND GENOMIC ACTION OF ESTROGEN J. Biol. Chem., September 14, 2007; 282(37): 27478 - 27492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Boulware, H. Kordasiewicz, and P. G. Mermelstein Caveolin Proteins Are Essential for Distinct Effects of Membrane Estrogen Receptors in Neurons J. Neurosci., September 12, 2007; 27(37): 9941 - 9950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Stender, J. Frasor, B. Komm, K. C. N. Chang, W. L. Kraus, and B. S. Katzenellenbogen Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation Mol. Endocrinol., September 1, 2007; 21(9): 2112 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Heneweer, R. Houtman, J. Poortman, M. Groot, C. Maliepaard, and A. Peijnenburg Estrogenic Effects in the Immature Rat Uterus after Dietary Exposure to Ethinylestradiol and Zearalenone Using a Systems Biology Approach Toxicol. Sci., September 1, 2007; 99(1): 303 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deschenes, V. Bourdeau, J. H. White, and S. Mader Regulation of GREB1 Transcription by Estrogen Receptor {alpha} through a Multipartite Enhancer Spread Over 20 kb of Upstream Flanking Sequences J. Biol. Chem., June 15, 2007; 282(24): 17335 - 17339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Naciff, G. J. Overmann, S. M. Torontali, G. J. Carr, Z. S. Khambatta, J. P. Tiesman, B. D. Richardson, and G. P. Daston Uterine Temporal Response to Acute Exposure to 17{alpha}-Ethinyl Estradiol in the Immature Rat Toxicol. Sci., June 1, 2007; 97(2): 467 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nguyen, M. Bail, G. Pesant, V. N. Dupont, E. Rouault, J. Deschenes, W. Rocha, G. Melancon, S. V. Steinberg, and S. Mader Rational design of an estrogen receptor mutant with altered DNA-binding specificity Nucleic Acids Res., May 11, 2007; 35(10): 3465 - 3477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Martin, M. B. Taylor, G. Krikun, C. Lockwood, G. E. Akbas, and H. S. Taylor Differential Cell-Specific Modulation of HOXA10 by Estrogen and Specificity Protein 1 Response Elements J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1920 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zhao, J. Matthews, M. Tujague, J. Wan, A. Strom, G. Toresson, E. W-F. Lam, G. Cheng, J.-A. Gustafsson, and K. Dahlman-Wright Estrogen Receptor {beta}2 Negatively Regulates the Transactivation of Estrogen Receptor {alpha} in Human Breast Cancer Cells Cancer Res., April 15, 2007; 67(8): 3955 - 3962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Menendez, A. Inga, J. Snipe, O. Krysiak, G. Schonfelder, and M. A. Resnick A Single-Nucleotide Polymorphism in a Half-Binding Site Creates p53 and Estrogen Receptor Control of Vascular Endothelial Growth Factor Receptor 1 Mol. Cell. Biol., April 1, 2007; 27(7): 2590 - 2600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lupien, M. Jeyakumar, E. Hebert, K. Hilmi, D. Cotnoir-White, C. Loch, A. Auger, G. Dayan, G.-A. Pinard, J.-M. Wurtz, et al. Raloxifene and ICI182,780 Increase Estrogen Receptor-{alpha} Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12 Mol. Endocrinol., April 1, 2007; 21(4): 797 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Kwon, I. Garcia-Bassets, K. R. Hutt, C. S. Cheng, M. Jin, D. Liu, C. Benner, D. Wang, Z. Ye, M. Bibikova, et al. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor {alpha}-binding program on human gene promoters PNAS, March 20, 2007; 104(12): 4852 - 4857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Al-Dhaheri and B. G. Rowan Protein Kinase A Exhibits Selective Modulation of Estradiol-Dependent Transcription in Breast Cancer Cells that Is Associated with Decreased Ligand Binding, Altered Estrogen Receptor {alpha} Promoter Interaction, and Changes in Receptor Phosphorylation Mol. Endocrinol., February 1, 2007; 21(2): 439 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Roemer, D. C. Donham, L. Sherman, V. H. Pon, D. P. Edwards, and M. E. A. Churchill Structure of the Progesterone Receptor-Deoxyribonucleic Acid Complex: Novel Interactions Required for Binding to Half-Site Response Elements Mol. Endocrinol., December 1, 2006; 20(12): 3042 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xu, W. Zhang, J. Klaus, J. Young, I. Koerner, L. C. Sheldahl, P. D. Hurn, F. Martinez-Murillo, and N. J. Alkayed Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection PNAS, September 26, 2006; 103(39): 14489 - 14494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wagner, S. Weber, M. A. Kleinschmidt, K. Nagata, and U.-M. Bauer SET-mediated Promoter Hypoacetylation Is a Prerequisite for Coactivation of the Estrogen-responsive pS2 Gene by PRMT1 J. Biol. Chem., September 15, 2006; 281(37): 27242 - 27250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhu, L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor Cells Cancer Res., August 15, 2006; 66(16): 7991 - 7998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Carroll and M. Brown Estrogen Receptor Target Gene: An Evolving Concept Mol. Endocrinol., August 1, 2006; 20(8): 1707 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wei and S. T. Jensen GAME: detecting cis-regulatory elements using a genetic algorithm Bioinformatics, July 1, 2006; 22(13): 1577 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Stossi, V. S. Likhite, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Estrogen-occupied Estrogen Receptor Represses Cyclin G2 Gene Expression and Recruits a Repressor Complex at the Cyclin G2 Promoter J. Biol. Chem., June 16, 2006; 281(24): 16272 - 16278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sharma, N. K. Saxena, N. E. Davidson, and P. M. Vertino Restoration of Tamoxifen Sensitivity in Estrogen Receptor-Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor Complexes. Cancer Res., June 15, 2006; 66(12): 6370 - 6378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-W Jeong, K Y Lee, J P Lydon, and F J DeMayo Steroid hormone regulation of Clca3 expression in the murine uterus. J. Endocrinol., June 1, 2006; 189(3): 473 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Boverhof, J. C. Kwekel, D. G. Humes, L. D. Burgoon, and T. R. Zacharewski Dioxin Induces an Estrogen-Like, Estrogen Receptor-Dependent Gene Expression Response in the Murine Uterus Mol. Pharmacol., May 1, 2006; 69(5): 1599 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Gururaj, R. R. Singh, S. K. Rayala, C. Holm, P. den Hollander, H. Zhang, S. Balasenthil, A. H. Talukder, G. Landberg, and R. Kumar MTA1, a transcriptional activator of breast cancer amplified sequence 3 PNAS, April 25, 2006; 103(17): 6670 - 6675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Moran, G. L. Warren, and D. A. Lowe Removal of ovarian hormones from mature mice detrimentally affects muscle contractile function and myosin structural distribution J Appl Physiol, February 1, 2006; 100(2): 548 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Lin, Y.-L. Tsai, M.-T. Huang, Y.-P. Lu, C.-T. Ho, S.-F. Tseng, and S.-C. Teng Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway Carcinogenesis, January 1, 2006; 27(1): 131 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J M O'Donnell, K. G Macleod, D. J Burns, J. F Smyth, and S. P Langdon Estrogen receptor-{alpha} mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen Endocr. Relat. Cancer, December 1, 2005; 12(4): 851 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Horner-Glister, M Maleki-Dizaji, C J Guerin, S M Johnson, J Styles, and I N H White Influence of oestradiol and tamoxifen on oestrogen receptors-{alpha} and -{beta} protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells J. Mol. Endocrinol., December 1, 2005; 35(3): 421 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Houdeau, A Levy, and S Mhaouty-Kodja Up-regulation of rat myometrial phospholipases C{beta}1 and C{beta}3 correlates with increased term sensitivity to carbachol and oxytocin J. Endocrinol., November 1, 2005; 187(2): 197 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, X. Li, C. A. Maguire, R. Hilf, R. A. Bambara, and M. Muyan Binding of Estrogen Receptor {beta} to Estrogen Response Element in Situ Is Independent of Estradiol and Impaired by Its Amino Terminus Mol. Endocrinol., November 1, 2005; 19(11): 2696 - 2712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Moreno, F. Perez-Jimenez, C. Marin, P. Perez-Martinez, R. Moreno, P. Gomez, Y. Jimenez-Gomez, J. A. Paniagua, D. Lairon, and J. Lopez-Miranda The Apolipoprotein E Gene Promoter (-219G/T) Polymorphism Determines Insulin Sensitivity in Response to Dietary Fat in Healthy Young Adults J. Nutr., November 1, 2005; 135(11): 2535 - 2540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S K Nair, T J Thomas, N J Greenfield, A Chen, H He, and T Thomas Conformational dynamics of estrogen receptors {alpha} and {beta} as revealed by intrinsic tryptophan fluorescence and circular dichroism J. Mol. Endocrinol., October 1, 2005; 35(2): 211 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Kazi, J. M. Jones, and R. D. Koos Chromatin Immunoprecipitation Analysis of Gene Expression in the Rat Uterus in Vivo: Estrogen-Induced Recruitment of Both Estrogen Receptor {alpha} and Hypoxia-Inducible Factor 1 to the Vascular Endothelial Growth Factor Promoter Mol. Endocrinol., August 1, 2005; 19(8): 2006 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Naciff, K. A. Hess, G. J. Overmann, S. M. Torontali, G. J. Carr, J. P. Tiesman, L. M. Foertsch, B. D. Richardson, J. E. Martinez, and G. P. Daston Gene Expression Changes Induced in the Testis by Transplacental Exposure to High and Low Doses of 17{alpha}-Ethynyl Estradiol, Genistein, or Bisphenol A Toxicol. Sci., August 1, 2005; 86(2): 396 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Shah, M. Al-Dhaheri, Y. Dong, C. Ip, F. E. Jones, and B. G. Rowan Selenium disrupts estrogen receptor {alpha} signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells Mol. Cancer Ther., August 1, 2005; 4(8): 1239 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mirkin, M. Arslan, D. Churikov, A. Corica, J.I. Diaz, S. Williams, S. Bocca, and S. Oehninger In search of candidate genes critically expressed in the human endometrium during the window of implantation Hum. Reprod., August 1, 2005; 20(8): 2104 - 2117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Boulware, J. P. Weick, B. R. Becklund, S. P. Kuo, R. D. Groth, and P. G. Mermelstein Estradiol Activates Group I and II Metabotropic Glutamate Receptor Signaling, Leading to Opposing Influences on cAMP Response Element-Binding Protein J. Neurosci., May 18, 2005; 25(20): 5066 - 5078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stepanova, T. Tiazhelova, M. Skoblov, and A. Baranova A comparative analysis of relative occurrence of transcription factor binding sites in vertebrate genomes and gene promoter areas Bioinformatics, May 1, 2005; 21(9): 1789 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Shah and B. G. Rowan The Src Kinase Pathway Promotes Tamoxifen Agonist Action in Ishikawa Endometrial Cells through Phosphorylation-Dependent Stabilization of Estrogen Receptor {alpha} Promoter Interaction and Elevated Steroid Receptor Coactivator 1 Activity Mol. Endocrinol., March 1, 2005; 19(3): 732 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y-L Zhao, W-D Han, Q Li, Y-M Mu, X-C Lu, L Yu, H-J Song, X Li, J-M Lu, and C-Y Pan Mechanism of transcriptional regulation of LRP16 gene expression by 17-{beta} estradiol in MCF-7 human breast cancer cells J. Mol. Endocrinol., February 1, 2005; 34(1): 77 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. DeNardo, H.-T. Kim, S. Hilsenbeck, V. Cuba, A. Tsimelzon, and P. H. Brown Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes Mol. Endocrinol., February 1, 2005; 19(2): 362 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Jung, M. B. Gatch, and J. W. Simpkins Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms Experimental Biology and Medicine, January 1, 2005; 230(1): 8 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Piccone, G. A. Brazeau, and K. M. McCormick Effect of oestrogen on myofibre size and myosin expression in growing rats Exp Physiol, January 1, 2005; 90(1): 87 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tang, S. L. Tan, S. K. Ramadoss, A. P. Kumar, M.-H. E. Tang, and V. B. Bajic Computational method for discovery of estrogen responsive genes Nucleic Acids Res., December 1, 2004; 32(21): 6212 - 6217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ashby and J. Odum Gene Expression Changes in the Immature Rat Uterus: Effects of Uterotrophic and Sub-Uterotrophic Doses of Bisphenol A Toxicol. Sci., December 1, 2004; 82(2): 458 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Das, R. C. Peterson, and W. M. Scovell High Mobility Group B Proteins Facilitate Strong Estrogen Receptor Binding to Classical and Half-Site Estrogen Response Elements and Relax Binding Selectivity Mol. Endocrinol., November 1, 2004; 18(11): 2616 - 2632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Stokes, B. Alston-Mills, and C. Teng Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor {alpha}-mediated transactivation activity in mammary gland cells J. Mol. Endocrinol., October 1, 2004; 33(2): 315 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C M Klinge, S C Jernigan, K A Mattingly, K E Risinger, and J Zhang Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors {alpha} and {beta} by coactivators and corepressors J. Mol. Endocrinol., October 1, 2004; 33(2): 387 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, J. Huang, P. Yi, R. A. Bambara, R. Hilf, and M. Muyan Single-Chain Estrogen Receptors (ERs) Reveal that the ER{alpha}/{beta} Heterodimer Emulates Functions of the ER{alpha} Dimer in Genomic Estrogen Signaling Pathways Mol. Cell. Biol., September 1, 2004; 24(17): 7681 - 7694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shao, E. K. Keeton, D. P. McDonnell, and M. Brown Coactivator AIB1 links estrogen receptor transcriptional activity and stability PNAS, August 10, 2004; 101(32): 11599 - 11604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O'Lone, M. C. Frith, E. K. Karlsson, and U. Hansen Genomic Targets of Nuclear Estrogen Receptors Mol. Endocrinol., August 1, 2004; 18(8): 1859 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. T. Gaddy, J. T. Barrett, J. N. Delk, A. M. Kallab, A. G. Porter, and P. V. Schoenlein Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells Clin. Cancer Res., August 1, 2004; 10(15): 5215 - 5225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mishra, A. H. Talukder, A. E. Gururaj, Z. Yang, R. R. Singh, M. G. Mahoney, C. Franci, R. K. Vadlamudi, and R. Kumar Upstream Determinants of Estrogen Receptor-{alpha} Regulation of Metastatic Tumor Antigen 3 Pathway J. Biol. Chem., July 30, 2004; 279(31): 32709 - 32715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. O. Mueller, S. Simon, K. Chae, M. Metzler, and K. S. Korach Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor {alpha} (ER{alpha}) and ER{beta} in Human Cells Toxicol. Sci., July 1, 2004; 80(1): 14 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Stossi, D. H. Barnett, J. Frasor, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) {alpha} or ER{beta} in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors Endocrinology, July 1, 2004; 145(7): 3473 - 3486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kretz, L. Fester, U. Wehrenberg, L. Zhou, S. Brauckmann, S. Zhao, J. Prange-Kiel, T. Naumann, H. Jarry, M. Frotscher, et al. Hippocampal Synapses Depend on Hippocampal Estrogen Synthesis J. Neurosci., June 30, 2004; 24(26): 5913 - 5921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bourdeau, J. Deschenes, R. Metivier, Y. Nagai, D. Nguyen, N. Bretschneider, F. Gannon, J. H. White, and S. Mader Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse Mol. Endocrinol., June 1, 2004; 18(6): 1411 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Tsai, J. A. Katzenellenbogen, B. S. Katzenellenbogen, and M. A. Shupnik Protein Kinase A Activation of Estrogen Receptor {alpha} Transcription Does Not Require Proteasome Activity and Protects the Receptor from Ligand-Mediated Degradation Endocrinology, June 1, 2004; 145(6): 2730 - 2738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. R. Ee, S. Kamalakaran, D. Tonetti, X. He, D. D. Ross, and W. T. Beck Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene Cancer Res., February 15, 2004; 64(4): 1247 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-C Lambert, N Coyle, and C Lendon The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease J. Med. Genet., February 1, 2004; 41(2): 104 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Naciff and G. P. Daston Toxicogenomic Approach to Endocrine Disrupters: Identification of a Transcript Profile Characteristic of Chemicals with Estrogenic Activity Toxicol Pathol, February 1, 2004; 32(2_suppl): 59 - 70. [Abstract] [PDF]
|
|
|
|
|
|
M. C. Frith, U. Hansen, J. L. Spouge, and Z. Weng Finding functional sequence elements by multiple local alignment Nucleic Acids Res., January 2, 2004; 32(1): 189 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Ramsey, K. E. Risinger, S. C. Jernigan, K. A. Mattingly, and C. M. Klinge Estrogen Receptor {beta} Isoforms Exhibit Differences in Ligand-Activated Transcriptional Activity in an Estrogen Response Element Sequence-Dependent Manner Endocrinology, January 1, 2004; 145(1): 149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Davis, M. L. Seney, H. J. Walker, and S. A. Tobet Differential Colocalization of Islet-1 and Estrogen Receptor {alpha} in the Murine Preoptic Area and Hypothalamus during Development Endocrinology, January 1, 2004; 145(1): 360 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Coser, J. Chesnes, J. Hur, S. Ray, K. J. Isselbacher, and T. Shioda Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray PNAS, November 25, 2003; 100(24): 13994 - 13999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Li and D. E. Ong Cellular Retinoic Acid-binding Protein II Gene Expression Is Directly Induced by Estrogen, but Not Retinoic Acid, in Rat Uterus J. Biol. Chem., September 12, 2003; 278(37): 35819 - 35825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Matthews and J.-A. Gustafsson Estrogen Signaling: A Subtle Balance Between ER{alpha} and ER{beta} Mol. Interv., August 1, 2003; 3(5): 281 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Bajic, S. L. Tan, A. Chong, S. Tang, A. Strom, J.-A. Gustafsson, C.-Y. Lin, and E. T. Liu Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes Nucleic Acids Res., July 1, 2003; 31(13): 3605 - 3607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. M. Kelley, B. G. Rowan, and M. Ratnam Modulation of the Folate Receptor {alpha} Gene by the Estrogen Receptor: Mechanism and Implications in Tumor Targeting Cancer Res., June 1, 2003; 63(11): 2820 - 2828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Wang, X. Y. Yang, X. Zhang, K. Mihalic, W. Xiao, and W. L. Farrar The cis Decoy against the Estrogen Response Element Suppresses Breast Cancer Cells via Target Disrupting c-fos not Mitogen-activated Protein Kinase Activity Cancer Res., May 1, 2003; 63(9): 2046 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Naciff, G. J. Overmann, S. M. Torontali, G. J. Carr, J. P. Tiesman, B. D. Richardson, and G. P. Daston Gene Expression Profile Induced by 17{alpha}-Ethynyl Estradiol in the Prepubertal Female Reproductive System of the Rat Toxicol. Sci., April 1, 2003; 72(2): 314 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Ponomarenko, T. I. Merkulova, G. V. Orlova, O. N. Fokin, E. V. Gorshkova, A. S. Frolov, V. P. Valuev, and M. P. Ponomarenko rSNP_Guide, a database system for analysis of transcription factor binding to DNA with variations: application to genome annotation Nucleic Acids Res., January 1, 2003; 31(1): 118 - 121. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||